|
E1
|
Upper left, eyelid
|
|
E2
|
Lower left, eyelid
|
|
E3
|
Upper right, eyelid
|
|
E4
|
Lower right, eyelid
|
|
EA
|
Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy
|
|
EB
|
Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy
|
|
EC
|
Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy
|
|
ED
|
Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
|
|
EE
|
Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
|
|
EJ
|
Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab
|
|
EM
|
Emergency reserve supply (for esrd benefit only)
|
|
EP
|
Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program
|
|
ER
|
Items and services furnished by a provider-based, off-campus emergency department
|
|
ET
|
Emergency services
|
|
EX
|
Expatriate beneficiary
|
|
EY
|
No physician or other licensed health care provider order for this item or service
|